Robuta

https://www.wikidata.org/wiki/Q43785779 The expression of MHC antigens by human teratocarcinoma derived cell lines. - Wikidata scientific article published in May 1981 the expression mhc antigens https://www.techtransfer.nih.gov/patent/e-221-1995-0-pct-02 MHC-CLASS II RESTRICTED MELANOMA ANTIGENS AND THEIR USE IN THERAPEUTIC METHODS | Technology Transfer https://www.techtransfer.nih.gov/patent/e-050-2014-0-fr-26 CANCER IMMUNOTHERAPY BY DELIVERING CLASS II MHC ANTIGENS AND A COSTIMULATORY SIGNAL PROTEIN USING A... https://www.techtransfer.nih.gov/patent/e-050-2014-0-ie-28 CANCER IMMUNOTHERAPY BY DELIVERING CLASS II MHC ANTIGENS AND A COSTIMULATORY SIGNAL PROTEIN USING A... https://scholars.duke.edu/publication/785630 Scholars@Duke publication: MHC class I-presented lung cancer-associated tumor antigens identified... mhc class i https://www.techtransfer.nih.gov/patent/e-050-2014-0-cn-21 Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon | Technology Transfer https://www.techtransfer.nih.gov/patent/e-050-2014-0-sg-14 Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon | Technology Transfer https://pubmed.ncbi.nlm.nih.gov/6164637/ Nomenclature for chicken MHC (B) antigens defined by monoclonal antibodies Nomenclature for chicken MHC (B) antigens defined by monoclonal antibodies nomenclature chicken mhc b antigens https://pubmed.ncbi.nlm.nih.gov/32820119/ Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage Intestinal microbiota have been proposed to induce commensal-specific memory T cells that cross-react with tumor-associated antigens. We identified major... mhc class i https://scholars.duke.edu/publication/726596 Scholars@Duke publication: MHC class I-presented tumor antigens identified in ovarian cancer by... https://www.techtransfer.nih.gov/patent/e-050-2014-0-ep-20 Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon | Technology Transfer https://www.techtransfer.nih.gov/patent/e-050-2014-0-be-22 CANCER IMMUNOTHERAPY BY DELIVERING CLASS II MHC ANTIGENS AND A COSTIMULATORY SIGNAL PROTEIN USING A...